Longboard Pharmaceuticals, Inc. (LBPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 137.04M |
| Enterprise Value | 123.18M |
| P/E Ratio | -25.1 |
| PEG Ratio | -4.43 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 33.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -41.02 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.07 |
| Return On Equity | -1.06 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5,000 |
| EBITDA | -56.75M |
| Net Income | -54.42M |
| Diluted EPS | -2.39 |
Balance Sheet
| Total Cash | 288.45M |
| Total Cash/Share | 2.13 |
| Total Debt | 3.73M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.14 |
| Book Value Per Share | 1.8 |
Price History
| 52-Week Change | 894.69 |
| 52-Week High | 59.98 |
| 52-Week Low | 59.98 |
| Moving Average 50 Days | 0 |
| Moving Average 200 Days | 0 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 39.05M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
